Startup Pinnacle Medicines is developing peptide drugs with the same efficacy as biologic medicines and the dosing convenience of oral small molecules. The lead program of OrbiMed-incubated Pinnacle is on track to enter the clinic in asthma and chronic obstructive pulmonary disease.
The post Pinnacle Medicines Adds $89M for Oral Peptides With Properties of Injectable Biologics appeared first on MedCity News.
Germany Doxes “UNKN,” Head of RU Ransomware Gangs REvil, GandCrab
An elusive hacker who went by the handle “UNKN” and ran the early Russian ransomware groups GandCrab and REvil now has a name and a
